Lipid Bilayer and Membrane Proteins

The lipid bilayer and its associated membrane proteins form the essential boundary of the cell, serving as both a protective barrier and a sophisticated communication hub. The bilayer itself is composed of amphiphilic phospholipids that organize into a fluid matrix, while membrane proteins—categorized as integral, peripheral, or lipid-anchored—facilitate the transport of ions and molecules, signal transduction, and cell-cell recognition [1]. Membrane proteins represent the most significant class of therapeutic targets, accounting for over 50% of all FDA-approved drug targets, including G protein-coupled receptors (GPCRs), ion channels, and transporters [2][3]. Pathological states often involve the dysfunction of these components, such as the overexpression of growth factor receptors in cancer or the malfunction of ion channels in cardiac arrhythmias [3]. Pharmacological intervention can involve direct binding to protein active sites, allosteric modulation, or the physical disruption of the lipid environment to alter cellular permeability [4][6]. Understanding the complex interplay between the lipid environment and protein conformation is crucial for the development of effective membrane-targeted therapies [5]. References: [1] Alberts B, et al. Molecular Biology of the Cell (2014). [2] Santos R, et al. Nat Rev Drug Discov (2017). [3] Overington JP, et al. Nat Rev Drug Discov (2006). [4] Bagatolli LA, et al. Biochim Biophys Acta (2010). [5] Stansfeld PJ, et al. Chem Rev (2017). [6] PubChem (Daptomycin). [7] StatPearls (Amphotericin B).

Other names

Cell membranePlasma membraneBiological membranePhospholipid bilayer

Drugs targeting this system act through diverse mechanisms: direct binding and modulation of integral membrane proteins (e.g., GPCR agonism/antagonism), pore formation or disruption of the lipid bilayer integrity (e.g., lipopeptide antibiotics), and alteration of membrane-bound enzyme activity or transport kinetics [2][6][7].